4.71% -0.31

Cartesian Therapeutics Inc (RNAC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Cartesian Therapeutics Inc Azioni (RNAC) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	100.00% -	0.078	0.947	0.452	0.298
Operating Expenses	9.70% 29.16	26.58	79.59	21.52	22.11
Operating Income/Loss	10.02% -29.16	-26.50	-78.64	-21.07	-21.81
Nonoperating Income/Loss	454.21% 44.92	-12.68	-	-	-
Net Income/Loss	140.25% 15.77	-39.18	-92.58	-35.90	15.89
Basic Average Shares	9.73% 29.47	26.86	0.011	26.00	25.98
Diluted Average Shares	11.19% 29.86	26.86	0.011	26.00	26.45
Basic Earnings Per Share	132.19% 0.47	-1.46	-3.57	-1.38	0.51
Diluted Earnings Per Share	131.51% 0.46	-1.46	-3.57	-1.38	0.50
Undistributed Earnings/Loss Allocated To Participating Securities, Basic	2.049	-	-	-	2.628

OLMA

$6.58

4.22%

ZVRA

$9.94

3.21%

SLDB

$5.53

3.66%

AVTX

$11.27

6.16%

NVCT

$18.60

1.74%

WVE

$3.13

1.88%